INNOVADERM EST MAINTENANT INDERO.

Episode 20: Guillaume Gigon, Christian Dansereau and Nardin Nakhla—AI-Driven Drug Development and Clinical Trials

Episode Notes Resources: [email protected]: Use this email to let us know what you want to hear about. Welcome to today’s episode, which delves into Artificial Intelligence (AI)-driven drug development and clinical trials. Three guest speakers will join the roundtable: Guillaume Gigon, Vice President of Technology and AI at Innovaderm; Nardin Nakhla, Co-Founder and CTO of […]

Episode 18: Faiza Tayar – Key Considerations in Site Selection

Episode Notes Resources: [email protected]: Use this email to let us know what you want to hear about. Welcome to our latest episode, featuring Faiza Tayar. With over 16 years of experience in the pharmaceutical industry, Faiza has been instrumental as a site selection manager at Innovaderm.  Her strategic insights have not only shaped her career […]

Episode 17: Despina Vasiliou—Insights from Regulatory Affairs Professionals Society Convergence 2024

Episode Notes Resources: [email protected]: Use this email to let us know what you want to hear about. We are delighted to welcome Despina Vasiliou, Innovaderm’s Regulatory Affairs Manager, who brings 8 years of industry experience. Known for her deep understanding of the regulatory landscape, Despina combines an analytical, scientific approach with strong organizational skills, making […]

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.